About Anthony Hyman, Ph.D.
Anthony Hyman, Ph.D. is a director at Dewpoint Therapeutics.
Anthony Hyman, Ph.D. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Hyman, Ph.D. in the role, so the role may have started earlier or lasted longer.
Dewpoint Therapeutics, Inc.
Director
2020 – 2026 · Boston, MA
Develops drug candidates for people with cancer and neurological diseases.
Key Colleagues at Startups
The people Anthony Hyman, Ph.D. works with at each company, as listed on that company's latest Form D.
Dewpoint Therapeutics, Inc. · Form D/A, Jul 13, 2026
ID
Isaac Klein, M.D., Ph.D.
Chief Scientific Officer and Head of R&D
RD
Regina Barzilay, Ph.D.
Director
SD
Steven Neier, Ph.D.
Director
AD
Ameet Nathwani, M.D.
Chief Executive Officer and director
GD
Giuseppe Ciaramella, Ph.D.
Director
MD
Mark Murcko, Ph.D.
Director
SD
Srinivas Akkaraju, M.D., Ph.D.
Director
OD
Olivier Brandicourt, M.D.
Director
AD
Amir Nashat, Sc.D.
Director
RD
Richard Young, Ph.D.
Director